Skip to main content
Premium Trial:

Request an Annual Quote

NCICB Seeks Comment, Geospiza, Oracle Life Sciences Users Group Meeting, NCI, FDA Host Biomarker Workshop

Premium

NCICB Seeks Comment on Data Standards Draft

The National Cancer Institute Center for Bioinformatics has released for public comment a draft document covering data content standards for clinical and basic science.

NCICB said it commissioned SAIC to review current data content standards in order to prepare the draft, which is available for a two-week public comment period at ftp://ftp1.nci.nih.gov/pub/cacore/ExternalStds/.

NCICB said it plans to incorporate comments and to release a final version of the document by the end of June.


Geospiza Partners with AME, Biomax

Geospiza last week announced reseller partnerships with AME Bioscience and Biomax Solutions.

In the AME deal, Geospiza’s Finch Sequencing Center software system will be bundled with refurbished or pre-owned sequencing instruments from Applied Biosystems and Amersham Bioscience (Now GE Healthcare).

Under the Biomax agreement, the firms will integrate sell their software together in a package called the Optimized Research Environment.


Oracle Holds Life Science User Group Meeting

Oracle will be hosting its fourth Oracle Life Sciences Users Group Meeting, June 23-24 in Reston, Va.

A full agenda and registration information are available at http://otn.oracle.com/industries/life_sciences/olsug/olsug_june2004.html.


NCI, FDA Host Biomarker Validation Workshop

The National Cancer Institute and the Food and Drug Administration will host a workshop in Bethesda, Md., on July 28-29 called, “Research Strategies, Study Designs and Statistical Approaches to Biomarkers Validation for Cancer Diagnosis and Detection.”

The workshop will address study design, statistical methodologies, and validation approaches to cancer biomarkers, and consider approaches to their validation for clinical utility.

A major goal of the workshop, according to the organizers, is “to develop a position paper on state-of-the-art in biomarker validation study.”

Additional information is available at http://www.scgcorp.com/biomarkers2004/.

Filed under

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.